Amethis Europe Expansion invests in HB Aesthetics, a European player in the professional cosmetics market.
WHO: Founded in 2014 by Raphaël Chauchard-Rios, a French entrepreneur, HB Aesthetics (HBA) designs and distributes high-end dermocosmetic products intended mainly for professional distribution (dermatologists, clinics, beauty institutes, and spas). Based in Vilafant, in the heart of the Spanish cosmetic valley, the company is vertically integrated with internal R&D structure, production capacity, and training centers. HBA’s products are currently distributed in over 60 countries, and exports account for more than 95% of sales, most of which are made in Southeast Asia, the Middle East, and Europe.
The company has two brands. Fusion Meso offers a range of sterile serums to be used with various devices (microneedling, electroporation, microcurrents, ultrasound, etc.) and skincare products based on active ingredients from aesthetic medicine. Ekseption is a brand based on the properties of natural organic acids such as BHA, AHA, PHA. The complete line of professional peels and at-home skincare products to be used before and after professional treatments.
WHY: HBA is entering a new phase of growth supported by strategic and financial support of this investment. The company intends to accelerate its development by diversifying its distribution channels and markets, focusing on Africa and the Middle East, while continuing its penetration of the Asian, European, and North American markets, thanks to Amethis’ support. In parallel, HBA is building a new facility five times larger than the previous to absorb its future growth.
IN THEIR OWN WORDS: Raphael Chauchard-Rios, President and founder of HBA, said, “HBA is entering a new stage of its development with Amethis to become an international reference in dermocosmetics. Driven by common convictions, I am happy that the Amethis teams are teaming up with us in this entrepreneurial adventure and accompanying us on our growth and internationalization journey as well as on the professionalization of our ESG policy. Our new 4,500m2 factory, which will be operational in a few weeks, will enable us to meet the strong demand of our customers and the market, which are seduced by the quality of our products, my primary motivation as a formulation specialist."
Nicolas Manardo, and Romain Gauvrit, partners of Amethis, add, “We were impressed by the quality and the dynamism of Raphaël Chauchard-Rios and his team with whom we share the same entrepreneurial values. We would like to thank him for his trust in partnering with us. Amethis is convinced that the strategic positioning of HBA, with a real R&D differentiation, will allow it to pursue its strategy of conquest and capture an important part of the expected market growth. This investment reflects one of the key axes of Amethis’ investment strategy, which is to accompany, within the framework of primary operations, entrepreneurial stories with sustained organic growth internationally."
2 Article(s) Remaining